| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |